Stay updated on U3-1402 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the U3-1402 in NSCLC Clinical Trial page.

Latest updates to the U3-1402 in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study content changes are visible.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a minor metadata change that does not affect the study details or user experience. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary toggle and updated minor metadata/text labels (QC criteria wording and FEAR Act data), with the revision/version updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check34 days agoChange DetectedThe 'Last Update Posted (Estimated)' label was changed to 'Last Update Posted' on the Study Details page.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 in the page footer; no observable changes to the study details, content, layout, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section listing trial sites by state (California, Georgia, Massachusetts, Michigan, New York, Ohio, Pennsylvania, Tennessee, Texas, Washington). Updated page revision to v3.3.3 and removed the previous state-specific location blocks and the HHS Vulnerability Disclosure link.SummaryDifference0.6%

Stay in the know with updates to U3-1402 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the U3-1402 in NSCLC Clinical Trial page.